News & Views
Scientists make biomarkers breakthrough
Jul 15 2011
The study was undertaken by National Physical Laboratory (NPL), the University of Edinburgh and industrial partners Mologic, IBM's Watson Research Center and Pepscan Presto BV.
Research by the scientists has identified molecular differences between disease-indicating proteins and those which exist naturally through the study of antibodies.
The scientists focused on hCG, a hormone produced in pregnancy, and its subunit, hCGβ, which is released by some cancers, meaning that its detection could provide an early warning against tumours.
However, they are similar to normal growth hormones LH and FSH, which could previously have lead to false positives.
"This work answers one of the big questions in distinguishing biomarkers which are critical for identifying and treating serious diseases. We hope this breakthrough will underpin the development of a range of new diagnostic techniques and treatment," said Max Ryadnov, principal research scientist at the NPL.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria